Feature | Cardiovascular Ultrasound | July 07, 2015

ASE: Echocardiography Can Provide More Complete Picture of Hypertension

Joint document offers recommendations for using echo to guide treatment

ASE, echocardiography, hypertension, document, EACVI, JASE, Thomas H. Marwick

July 7, 2015 – A new document from the American Society of Echocardiography (ASE) provides detailed guidance for clinicians on how to use echocardiography to see the full picture of the condition of patients with hypertension. The paper, Recommendations on the Use of Echocardiography in Adult Hypertension: A Report from the European Association of Cardiovascular Imaging (EACVI) and the American Society of Echocardiography (ASE) is a joint project between ASE and the European Association of Cardiovascular Imaging (EACVI) and will appear in the July issue of the Journal of the American Society of Echocardiography (JASE).

Hypertension, or high blood pressure, is one of the leading risk factors for death globally, leading to a wide variety of cardiovascular problems, including coronary heart disease and stroke. While most of the general public are familiar with the traditional method of measuring blood pressure, systolic pressure over diastolic pressure, those numbers alone do not offer much information to physicians about the actual damage that may be occurring within a patient's cardiovascular system. 

Thomas H. Marwick, MBBS, Ph.D., of the Menzies Research Institute in Australia, commented, "While the primary goal of treatment is to reduce blood pressure to goal, echocardiographic measures of changes to the left ventricle (LV), for instance, can help predict prognosis. This is the first international recommendation on how to use echocardiography in this patient population."

The majority of the document outlines in detail the pathophysiology of cardiac responses to hypertension, which echocardiographic measures are most significant, and how to perform them most accurately.  "More research is still needed to show how clinicians can fully use the valuable information provided by echo to guide therapy and other clinical decisions," Marwick noted. "In the meantime, this paper represents a comprehensive guide on when, why, and how to gather the images and data that may influence clinician decision-making."

For more information: www.asecho.org

Related Content

Childhood Obesity and High Blood Pressure Warn of Future Heart Disease. Vivian Fornell playing doctor at the Elgin Public Library. Photo by Dave Fornell
News | Hypertension | April 30, 2020
April 30, 2020 — A large study in adolescents and children, some as young as 3 years of age, shows a link between obe
Aria CV Pulmonary Hypertension System_Aria CV PH System

The Aria CV Pulmonary Hypertension System.

News | Hypertension | February 27, 2020
February 27, 2020 — Aria CV Inc.
BackBeat CNT is the flagship therapy of Orchestra BioMed Inc. It is a bioelectronic treatment that immediately, substantially and chronically lowers blood pressure (BP) while simultaneously modulating the autonomic nervous system (ANS).

The BackBeat CNT system is a bioelectronic treatment that immediately, substantially and chronically lowers blood pressure (BP) while simultaneously modulating the autonomic nervous system (ANS). 

News | Hypertension | October 10, 2019
October 10.
Abnormal Blood Pressure in Middle And Late Life Influences Dementia Risk

Image courtesy of the American Heart Association

News | Hypertension | August 20, 2019
In a study that spanned two and a half decades and looked at data from more than 4,700 participants, Johns Hopkins...
Blood Pressure Control Less Likely Among Those Treated in Low-income Areas
News | Hypertension | August 14, 2019
People enrolled in a large clinical hypertension management trial were half as likely to control their blood pressure ...
Pediatricians Assess How to Personalize Hypertension Treatment in Children
News | Hypertension | July 29, 2019
High blood pressure among children is on the rise and a lack of research about how to treat it has left pediatricians...
BackBeat Cardiac Neuromodulation Therapy Shows Immediate, Substantial Blood Pressure Reduction
News | Hypertension | June 04, 2019
Orchestra BioMed Inc. announced the presentation of two-year clinical data from the European Moderato I study of...
St. Bartholomew's Hospital Initiates CALM-2 Hypertension Trial
News | Hypertension | February 20, 2019
California-based Vascular Dynamics Inc. (VDI) is sponsoring a new clinical trial, called CALM-2 (Controlling And...